INTRODUCTION 26
Real time glycemia is a cornerstone for metabolic research, particularly when 27 performing oral glucose tolerance tests (OGTT) 
METHODS 46
Two hundred ninety three plasma specimens from 13 OGTT and hyperinsulinemic 47 euglycemic clamps from subjects recruited in our ongoing research study were used for this 48
comparison. All subjects signed the IRB approved consent. 49
Immediately after drawing, 0.4 ml of blood was placed in microtubes containing 30 50 I.U. of Lithium-Heparin and 1 mg Sodium Fluoride per ml of blood as glucose preservative. 51
Both of these chemicals are known not to interfere with glucose oxidase measurements. 52
Microtubes were spun in a microcentrifuge and plasma was loaded simultaneously on both 53 the YSI and the Analox. These were previously calibrated as specified by the manufacturers. 54
Calibrations were repeated throughout the OGTT or clamps. Manufacturer's standards of 55 various known concentrations were used to assess quality of calibration throughout the tests. 56
All solutions were kept at 4 degrees Celsius as suggested by the manufacturers. 57
To analyze absolute differences, paired-sample T-tests were performed between YSI 58
and Analox results. Simple linear regression was used to confirm linear relationship and its 59 dispersion was assessed by standard error of estimation (SEE). To assess repeatability, the 60 regression line was compared to the identity line. Concordance correlation coefficient (CCC), 61 which contains both measurements of precision (p, Pearson correlation coefficient) and 62 accuracy (Cb, bias correction factor), was also computed. To confirm agreement a 63
Bland&Altman Plot was done. Reliability was assessed using intraclass coefficient correlation 64 The main finding of this study was that glycemia measured from YSI and Analox 86 were significantly different with both systematic and proportional errors. To our knowledge 87 this is the only study comparing the Analox to the YSI that can be seen as today's gold 88 standard(5). We did not find an acceptable agreement between the YSI and the Analox. 89
Reliability and concordance were modest. In addition, the Analox overestimated 99.7% of the 90
specimens. 91
Our results are in disagreement with the manufacturer information comparing 123 92 specimens measured by Analox and Beckman (http://www.analoxusa.com/analoxgm9info.htm). 93
They reported a well-fitted linear equation Y=1.005·X-0.073 (R 2 =0.998) which contrasts with the 94 one reported in this study Y=0.947·X+1.334 (R 2 =0.604). This discrepancy may be partially 95 explained by the wide range of concentrations used by the manufacturer to validate the GM9 96 (from 3.00 to 23.98 mmol/L) and the fact that few samples were in the euglycemic range, which 97 may introduce bias(6) and increase type I error. In contrast, we used human specimens in 98 
